Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Petah Tikvah

Petah Tikvah, IsraelNot linked to an institution yet

3running trials
0closed trials
0trials confirmed by the site in the last 60 days
–languages not stated

No trial has been confirmed here yet.

Running trials

Active, not recruiting
A Study of Acalabrutinib vs Investigator's Choice of Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in R/R CLL
NCT02970318· Phase 3· Source
Active, not recruiting
Study of Acalabrutinib (ACP-196) Versus Ibrutinib in Previously Treated Participants With High Risk Chronic Lymphocytic Leukemia (CLL)
NCT02477696· Phase 3· Source
Active, not recruiting
Acalabrutinib, Obinutuzumab and Chlorambucil in Treatment naïve CLL
NCT02475681· Phase 3· Source

Researchers

No researcher is linked here yet.

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Under construction, not live – Petah Tikvah: trial site – Frontlight Research